PNV is definitely not speculative. Alhambra just a troll. Speculative would imply the business is relying on FDA approval to sell product. This is absolutely not the case. Business has plenty of runway whether it is approved by any regulator or not. A speculative biotech company isn’t selling $60m of product. PNV is early stage growth with the possibility of becoming global standard of care across a few indications if market share growth continues
PNV - Banter and General Comments, page-10164
-
- There are more pages in this discussion • 1,993 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.67 |
Change
0.070(2.69%) |
Mkt cap ! $1.842B | |||
| Open | High | Low | Value | Volume |
| $2.63 | $2.76 | $2.62 | $10.48M | 3.925M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4520 | $2.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.67 | 20332 | 5 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |